Gastrointestinal Cancer
Original Report
Randomized trial of vitamin B6 for preventing hand-foot syndrome from capecitabine chemotherapy
News
Esophagectomy treatment response nodes provide prognostic information
Major finding: In 62 patients classified as having limited or no nodal involvement, the presence of treatment response nodes was associated with...
Reviews
Biomarker testing for treatment of metastatic colorectal cancer: role of the pathologist in community practice
The past decade has been marked by significant advancements in the treatment of patients with metastatic colorectal cancer (mCRC), including the...
News
IBD linked to increased risk of certain cancers
Major finding: In a population-based cohort study, patients with inflammatory bowel disease (IBD) were found to be at increased risk for...
News
Complications after gastric cancer resection portend poor outcomes
Major finding: Patients experiencing postoperative complications were more likely to die (HR, 1.6) and less likely to receive adjuvant therapy (48...
News
CTCs may aid diagnosis, staging of pancreatic cancer
Major finding: One CTC/2 mL of blood had 71% sensitivity and 95% specificity for the presence of pancreatic cancer and two CTCs/2 mL of blood had...
News
MicroRNA screening might reveal pancreatic cancer
Major finding: Two panels of microRNAs correctly diagnosed pancreatic cancer in 85% of affected patients and correctly diagnosed chronic...
News
Colorectal cancer incidence rising sharply among younger adults
Major finding: Between 2010 and 2030, the incidences of colon and rectal/rectosigmoid cancer are predicted to rise by 90% and 124% among 20- to 34...
Conference Coverage
Aspirin didn’t extend survival in PIK3CA-mutant colorectal cancer
Major finding: With a median follow-up of 46 months, the 26% of the study population who were regular aspirin users and the non-users had...
News
Neoadjuvant capecitabine equals infused 5-FU for rectal cancer
Major finding: Capecitabine and infused 5-FU yielded statistically indistinguishable rates of locoregional control approaching 90%.
Conference Coverage
Dual-vaccine therapy prolonged survival in pancreatic cancer
Major Finding: Compared with GVAX alone, GVAX followed by CRS-207 was associated with better overall survival (6.1 vs. 3.9 months; hazard ratio, 0...